Brian Wamhoff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ -- HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, participated in the Piper Sandler Spring Biopharma...

Cheryl Underwood and Brian Wamhoff spend about a month putting up a 200,000-light holiday display at Underwood's home.

/PRNewswire/ -- HemoShear Therapeutics, Inc., a privately held biotechnology company developing drugs for rare diseases, today announced the appointment of...

HemoShear Therapeutics Advances Second Novel Drug Target into Horizon Therapeutics plc Early Discovery Pipeline for Gout - Second Milestone Achieved by HemoShear in Exclusive Drug Discovery Collaboration - News provided by Share this article CHARLOTTESVILLE, Va., April 21, 2021 /PRNewswire/ --  HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, has identified a second drug target for the treatment of gout under its collaboration with Horizon Therapeutics plc (Nasdaq: HZNP) that was established in January 2019. Leveraging its proprietary REVEAL-Tx™ disease...

HemoShear Therapeutics Identifies Novel Drug Target to Treat NASH in Drug Discovery Partnership with Takeda Drug Target Will Advance into Takeda's Discovery Portfolio as Part of Ongoing Collaboration News provided by Share this article Share this article CHARLOTTESVILLE, Va., Dec. 10, 2020 /PRNewswire/ -- HemoShear Therapeutics, LLC, a privately held clinical stage biotechnology company, has achieved a research milestone in its discovery and development collaboration with Takeda Pharmaceutical Company Limited ("Takeda") to advance its first nonalcoholic steatohepatitis (NASH) target into Ta...